ECMC Annual Network Meeting - Wednesday 18 May 2016

Morning Plenary Session

• Agenda
• Reflection on the current quinquennium of the ECMC Network - Peter Johnson, Cancer Research UK
• Experience of the ECMC cross-centre placements and skills sharing scheme - Alan Bilsland, Glasgow and Karen Swales, ICR
• UK Therapeutic Cancer Prevention Network (UKTCPN) Update - Farhat Din, Edinburgh
• NCRI Cellular Molecular Pathology Initiative - Karin Oien, Glasgow and Bridget Wilkins, GSTT
• Opportunities and challenges associated with metastasis - an update from the Anti-Metastatic Consortium - Jeff Evans, Glasgow

Afternoon Parallel Sessions

Biopsies: is there such a thing as too much?

• Agenda
• Why do we inflict research biopsies on our patients? - Richard Baird, Cambridge
• Pathologist's point of view - Bridget Wilkins, GSTT 
• Patient experience - Helen Bulbeck

HRA Approval processes - operational overview for sponsors and host sites

• Agenda
• Presentation - Mark Terry, Wendy Fisher Consulting

Adaptive designs - an overview and some examples

• Agenda
• Presentation - Thomas Jaki, University of Lancaster

Precision Medicine Initiatives within the ECMC Network

• Agenda
• Presentations to follow